GH Research (GHRS) Other Non-Current Assets (2025)
GH Research (GHRS) recorded quarterly Other Non-Current Assets of $1.6 million in Q4 2025, up 40.62% quarter-over-quarter from $1.2 million in Q3 2025.
GH Research (GHRS) Other Non-Current Assets (2025) Analysis & Trends
GH Research's Other Non-Current Assets history runs 1 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets changed N/A year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (changed N/A YoY), while the FY2025 annual figure was $1.6 million, changed N/A from the prior year.
- Other Non-Current Assets was $1.6 million for Q4 2025 at GH Research, up from $1.2 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.7 million in Q2 2025 to a low of $1.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.09 Mn |